Literature DB >> 28821416

Short and long-term prognostic value of hyponatremia in heart failure with preserved ejection fraction versus reduced ejection fraction: An analysis of the Korean Acute Heart Failure registry.

Jin Joo Park1, Young-Jin Cho1, Il-Young Oh1, Hyun-Ah Park2, Hae-Young Lee3, Kye Hun Kim4, Byung-Su Yoo5, Seok-Min Kang6, Sang Hong Baek7, Eun-Seok Jeon8, Jae-Joong Kim9, Myeong-Chan Cho10, Shung Chull Chae11, Byung-Hee Oh3, Dong-Ju Choi12.   

Abstract

BACKGROUND: Hyponatremia is a well-known risk factor for worse outcomes in heart failure (HF) patients. The impact of hyponatremia according to the ejection fraction (EF) is unclear. We evaluated the prognostic value of hyponatremia according to HF type. METHODS AND
RESULTS: The Korea Acute Heart Failure (KorAHF) registry consecutively enrolled 5625 patients. Hyponatremia was defined as serum sodium level<135mmol/L at hospital admission. HF with preserved and reduced ejection fraction were defined as an LVEF ≥50% and LVEF ≤40%, respectively. Among 5103 patients with available EF, 2088 (60%) had HFrEF, and 1284 (25%) had HFpEF. There was no difference in serum sodium level between the groups (HFrEF: 137.4±4.7mmol/L vs. HFpEF: 137.5±5.0mmol/L, P=0.710). Hyponatremic patients had higher in-hospital mortality or urgent heart transplantation in all (11.3% vs. 4.5%, P<0.001), in HFrEF (13.1% vs. 4.9%, P<0.001), and in HFpEF (6.0% vs. 1.9%, P<0.001). After adjustment for significant covariates, hyponatremia was associated with 1.5 fold increased risk for 1-year post-discharge death in the HFrEF group (HR, 1.52; 95% CI, 1.24-1.86), but not in the HFpEF group (HR, 1.16; 95% CI, 0.84-1.61). During admission, the sodium status changed in 22% of the patients and the discharge sodium status had greater prognostic value.
CONCLUSIONS: Hyponatremia is independent of HF type. Hyponatremia is a significant risk factor for adverse in-hospital outcomes; however its long-term prognostic value is only limited to patients with HFrEF, but not for those with HFpEF.
Copyright © 2017 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Heart failure with preserved ejection fraction; Heart failure with reduced ejection fraction; Hyponatremia; Prognosis

Mesh:

Year:  2017        PMID: 28821416     DOI: 10.1016/j.ijcard.2017.08.004

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  8 in total

Review 1.  Paradigm Shifts of Heart Failure Therapy: Do We Need Another Paradigm?

Authors:  Hae-Young Lee; Byung-Hee Oh
Journal:  Int J Heart Fail       Date:  2020-04-06

2.  Racial differences and mortality risk in patients with heart failure and hyponatremia.

Authors:  Jeremy A Miles; Renato Quispe; Yonatan Mehlman; Kavisha Patel; Claudia Lama Von Buchwald; Jee Young You; Seth Sokol; Robert T Faillace
Journal:  PLoS One       Date:  2019-06-19       Impact factor: 3.240

3.  Do we need a simplified model to predict outcomes in patients hospitalized with Acute Decompensated Heart Failure? Results from The Role of Sodium in Heart Failure Outcomes Prediction ('SHOUT-PREDICTION') study.

Authors:  Shishir Soni; Yashwant Panwar; Anil Bharani
Journal:  Indian Heart J       Date:  2021-06-23

4.  Performance of Prognostic Risk Scores in Elderly Chinese Patients with Heart Failure.

Authors:  Yalin Cheng; Ke Chai; Wanrong Zhu; Yuhao Wan; Yaodan Liang; Minghui Du; Yingying Li; Ning Sun; Jiefu Yang; Hua Wang
Journal:  Clin Interv Aging       Date:  2021-09-16       Impact factor: 4.458

5.  Hyponatraemia, hyperglycaemia and worsening renal function at first blood sample on emergency department admission as predictors of in-hospital death in patients with dyspnoea with suspected acute heart failure: retrospective observational analysis of the PARADISE cohort.

Authors:  Tahar Chouihed; Aurélien Buessler; Adrien Bassand; Deborah Jaeger; Jean Marc Virion; Lionel Nace; Françoise Barbé; Sylvain Salignac; Patrick Rossignol; Faiez Zannad; Nicolas Girerd
Journal:  BMJ Open       Date:  2018-03-30       Impact factor: 2.692

6.  Reduced ejection fraction heart failure - new data from multicenter studies and national registries regarding general and elderly populations: hopes and disappointments.

Authors:  Simina Crişan; Lucian Petrescu; Mihai Andrei Lazăr; Cristina Văcărescu; Alina-Ramona Nicola; Dragoş Cozma; Cristian Mornoş; Constantin Tudor Luca
Journal:  Clin Interv Aging       Date:  2018-04-18       Impact factor: 4.458

7.  Biomarkers, myocardial fibrosis and co-morbidities in heart failure with preserved ejection fraction: an overview.

Authors:  Marta Michalska-Kasiczak; Agata Bielecka-Dabrowa; Stephan von Haehling; Stefan D Anker; Jacek Rysz; Maciej Banach
Journal:  Arch Med Sci       Date:  2018-06-11       Impact factor: 3.318

8.  Furosemide and spironolactone doses and hyponatremia in patients with heart failure.

Authors:  Ivan Velat; Željko Bušić; Marina Jurić Paić; Viktor Čulić
Journal:  BMC Pharmacol Toxicol       Date:  2020-08-03       Impact factor: 2.483

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.